Home
>
National Drug Code (NDC)
>
Banophen
Banophen - 50436-3762-1 - (Diphenhydramine Hydrochloride)
Drug Information of Banophen
| Product NDC: | 50436-3762 |
| Proprietary Name: | Banophen |
| Non Proprietary Name: | Diphenhydramine Hydrochloride |
| Active Ingredient(s): | 50 mg/1 & nbsp; Diphenhydramine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Banophen
| Product NDC: | 50436-3762 |
| Labeler Name: | Unit Dose Services |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part348 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20090102 |
Package Information of Banophen
| Package NDC: | 50436-3762-1 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (50436-3762-1) |
NDC Information of Banophen
| NDC Code | 50436-3762-1 |
| Proprietary Name | Banophen |
| Package Description | 30 CAPSULE in 1 BOTTLE (50436-3762-1) |
| Product NDC | 50436-3762 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Diphenhydramine Hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20090102 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Unit Dose Services |
| Substance Name | DIPHENHYDRAMINE HYDROCHLORIDE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
